Chile childhood vaccine schedule: 13 vaccines by age
For babies (first year): BCG (tuberculosis), Hepatitis B, DTaP / Tdap, Polio (IPV), Hib, Pneumococcal (PCV), Rotavirus, MMR, Varicella (chickenpox), Hepatitis A, Meningococcal. Click a vaccine for its Chile-specific page and its schedule in every other country.
| Vaccine | Status | Doses & recommended age |
|---|---|---|
| BCG (tuberculosis) · side effects & data | Universal | Dose 1 — At birth |
| Hepatitis B · side effects & data | Universal | Dose 1 — At birth (Hexavalent) Dose 2 — 2 months (Hexavalent) Dose 3 — 4 months (Hexavalent) Dose 4 — 6 months (Hexavalent) |
| DTaP / Tdap · side effects & data | Universal | Dose 1 — 2 months Dose 2 — 4 months Dose 3 — 6 months Booster — 18 months Booster — 4 years |
| Polio (IPV) · side effects & data | Universal | Dose 1 — 2 months (IPV then OPV) Dose 2 — 4 months (IPV then OPV) Dose 3 — 6 months (IPV then OPV) Booster — 18 months (IPV then OPV) Booster — 4 years (IPV then OPV) |
| Hib · side effects & data | Universal | Dose 1 — 2 months Dose 2 — 4 months Dose 3 — 6 months |
| Pneumococcal (PCV) · side effects & data | Universal | Dose 1 — 2 months Dose 2 — 4 months Booster — 12 months |
| Rotavirus · side effects & data | Universal | Dose 1 — 2 months (Rotavirus (oral)) Dose 2 — 4 months (Rotavirus (oral)) |
| MMR · side effects & data | Universal | Dose 1 — 12 months (Tres virica) Dose 2 — 5-6 years (Tres virica) |
| Varicella (chickenpox) · side effects & data | Universal | Dose 1 — 12 months (Varicela) Dose 2 — 5-6 years (Varicela) |
| Hepatitis A · side effects & data | Universal | Dose 1 — 18 months |
| Meningococcal · side effects & data | Universal | Dose 1 — 3 months (MenACWY conjugate) Dose 2 — 5 months (MenACWY conjugate) Booster — 12 months (MenACWY conjugate) |
| HPV · side effects & data | Universal | Dose 1 — 9-13 years Dose 2 — 6-12 months after dose 1 |
| Influenza (flu) · side effects & data | Universal | Annual — 6 months-5 years and risk groups, every season |
Chile vaccine schedule vs. the United States
Chile and the United States share 12 routine vaccines. Chile also routinely gives BCG (tuberculosis), which the U.S. does not. The U.S. routinely gives COVID-19, which Chile does not.
| Vaccine | Chile first dose | U.S. first dose | Doses |
|---|---|---|---|
| Hepatitis B | At birth | Birth | 4 vs 3 doses |
| DTaP / Tdap | 2 months | 2 months | 5 vs 5 doses |
| Polio (IPV) | 2 months | 2 months | 5 vs 4 doses |
| Hib | 2 months | 2 months | 3 vs 4 doses |
| Pneumococcal (PCV) | 2 months | 2 months | 3 vs 4 doses |
| Rotavirus | 2 months | 2 months | 2 vs 3 doses |
| MMR | 12 months | 12-15 months | 2 vs 2 doses |
| Varicella (chickenpox) | 12 months | 12-15 months | 2 vs 2 doses |
| Hepatitis A | 18 months | 12-23 months | 1 vs 2 doses |
| Meningococcal | 3 months | 11-12 years | 3 vs 2 doses |
| HPV | 9-13 years | 11-12 years | 2 vs 2 doses |
| Influenza (flu) | 6 months-5 years and risk groups, every season | 6 months and older, every season | 1 vs 1 doses |
In the Chile schedule but not the routine U.S. schedule: BCG (tuberculosis).
In the routine U.S. schedule but not Chile's: COVID-19.
Why Chile's schedule looks the way it does
Schedules differ mostly because disease burden and health-system conditions differ. WHO/UNICEF estimates of how many children actually receive each vaccine, and the diseases' reported incidence, explain most of the choices below.
- Tuberculosis: 19 new cases per 100,000 people per year (2024) — about 6× the U.S. rate. BCG is given to every newborn nationwide. BCG mainly protects young children from severe TB (meningitis, miliary TB), so countries with high TB incidence give it at birth and low-incidence countries reserve it for risk groups.
- Measles: 0.1 reported cases per million people (2025). Two-dose coverage is 78%; sustained elimination needs roughly 95% coverage with both doses, which is why schedules add or move the second dose when coverage or outbreaks change.
- Hepatitis B birth dose: 99% coverage. A birth dose matters most where mothers commonly carry hepatitis B, because infection at birth becomes chronic in most infants; countries with low carriage and universal prenatal screening often start hepatitis B vaccination later or target only exposed newborns.
- Rotavirus: no current national coverage estimate is reported to WHO, which usually means the vaccine is not (or not yet) in the universal schedule.
Coverage: share of children who received each vaccine (WHO/UNICEF estimates)
| Vaccine | Chile | United States |
|---|---|---|
| BCG (TB) | 99% (2025) | not reported |
| DTP dose 1 | 98% (2025) | 98% (2025) |
| DTP dose 3 | 95% (2025) | 94% (2025) |
| Measles dose 1 | 95% (2025) | 92% (2025) |
| Measles dose 2 | 78% (2025) | 95% (2025) |
| Polio (IPV series) | 95% (2025) | 93% (2025) |
| Hep B birth dose | 99% (2025) | 75% (2025) |
| Hep B dose 3 | 95% (2025) | 93% (2025) |
| Hib dose 3 | 95% (2025) | 92% (2025) |
| Pneumococcal (PCV) | 94% (2025) | 84% (2025) |
| Rotavirus (complete) | not reported | 77% (2025) |
| HPV dose 1, girls | 92% (2025) | 73% (2025) |
Source: WHO/UNICEF Estimates of National Immunization Coverage (WUENIC) and WHO reported incidence, via the WHO Immunization Data portal; TB incidence from the WHO Global Health Observatory (indicator MDG_0000000020). Retrieved 2026-10-09. "Not reported" usually means the vaccine is not in the universal schedule. Polio is the completed inactivated-polio series (IPVC).
Other Latin America countries
Argentina · Brazil · Colombia · Costa Rica · Ecuador · Honduras · Peru · Uruguay · all 31 countries